Pharmacy benefit managers found themselves under the microscope at a recent hearing of the US Senate Committee on Finance, as academics, legal experts and industry stakeholders examined the impact the business practices of these organizations have on the wider healthcare ecosystem.
Led by senators Ron Wyden, D-OR, who chairs the Senate Finance Committee, and Mike Crapo, R-ID, the hearing received testimony...



